Exhibition Dates: July 25 to July 28, 2024
Exhibition Hours: 10:00 AM – 6:00 PM daily (until 5:00 PM on the last day)
Exhibition Venue: Nangang Exhibition Center, Hall 1, 1st Floor, Zone K (No. 1, Jingmao 2nd Road, Nangang District, Taipei City)
Booth Numbers: K622, K624

Biotechnology ✕ Beauty and Health “Asia Healthcare & Medical Cosmetology Expo 2024” showcases projects covering biotech pharmaceuticals, medicine, beauty care, and health. This year, AM Biotech is also participating, presenting our exclusive “Bio-Pulsed” patented technology, scientifically backed beauty and hair care ingredient ExoGiov® Bio-Pulsed Exosomes, and eagerly anticipated new products.

AM Biotech’s Core Technologies

• Exclusive Bio-Pulsed Patent Technology
• Cutting-Edge Manufacturing Process for Mass Production
• Ultra-Purification Extraction Technology for Exosomes
• High-Efficiency Exosome Production Technology for Room Temperature Storage

Advantages of ExoGiov® Bio-Pulsed Exosome Ingredients

• Smooth Wrinkles, Tighten Skin: Promotes the growth of skin-related fibroblasts, anti-inflammation, collagen, and elastin production, with effects 10 to 16 times higher than ordinary exosomes.
• Brighten Skin, Even Out Skin Tone: Degrades melanin miRNA, hundreds of times more effective than ordinary exosomes.
• Strengthen Hair Roots, Revitalize Scalp: Promotes and activates follicle cell growth, with effects 5 to 6 times higher than ordinary exosomes.

Read Moreread more

Join Us at Cosmopack Asia 2025

2025-10-23

AM Biotech is honored to participate in Cosmopack Asia 2025, where we will present our

Join Us at the 2025 Autumn International Beauty & Cosmetics Show

2025-09-15

Ascension Medical Biotechnology is dedicated to the research and development of functionally induced exosomes. With

AM Biotech Expands into ASEAN Market at Malaysia-Taiwan Great Health Exhibition Centre

2025-07-18

Taiwan Great Health Exhibition Centre Opens in Kuala Lumpur, Showcasing Healthcare Innovation

“Ascension Medical Biotechnology Co. Ltd.” (AM BIOTECH) is a Taiwan medical biotechnology research company, producer of patented technology Bio-Pulsed Exosomes (Extracellular Vesicles), it is a Global Cross-Generation Innovative Cosmetic Ingredient recognized and favored by the international market in Europe and America.

AM BIOTECH is the exhibitor at In-cosmetics Global (Paris, France from April 16 to April 18, 2024) for its patented Bio-pulsed Exosomes (Extracellular Vesicles) raw materials and related derivatives products. In-cosmetics Global is a leading international cosmetics tradeshow annually for worldwide network of personal care ingredients and cosmetic ingredient; the exhibition displays the best achievements in the global cosmetics industry and can be called the “Oscars Global event for the cosmetics industry”. For personal care & cosmetics ingredients exhibitors, suppliers & manufactures included outstanding top cosmetic raw material suppliers such as BASF, Croda, Ashland, Solvay, Evonik, etc., exhibiting their new generation of innovative cosmetic raw materials. Leading international cosmetics brands and manufacturers such as L’Oreal, Unilever, Procter & Gamble, Estee Lauder, Kenvue, LVMH, etc. they are looking for excellent innovative cosmetic raw materials that comply with international regulations as a new generation of cutting-edge cosmetics for development and application.

ExoGiov® is a Biochemical-pulsed exosome; developed by AM BIOTECH; specifically designed for facial beauty and hair health. It is a specific-pathogen-free (SPF) chicken embryonic mesenchymal cell-derived extracellular vesicles, which is complies with international standards and regulations acceptable worldwide (INCI: chicken embryonic mesenchymal cell-derived extracellular vesicles). The Bio-pulsed exosome with inducing activated function is a self-developed patented cosmetic ingredient in combined the key 4 pillars innovation of (Clinical breakthroughs, Product innovation, Ingredient innovation, Research and Biotechnology innovation); its excellent efficacy results surpass ordinary exosomes and common cosmetic ingredients. The results and efficacy data were also published in the international Journal of Molecular Science.

AM BIOTECH Biochemical-pulsed exosome was selected as one of the top five innovation cosmetics raw materials in the world at 2024 in-cosmetics Global by the Estée Lauder Company’s New Incubation Ventures (NIV) BRKTHRU VOICES Prize. Hence, it is not only AM BIOTECH has the honor with international affirmation in advance medical research & innovation; but also, the opportunity to expand the worldwide market internationally for ExoGiov® Biochemical Pulsed Exosomes in important professional facial beauty & haircare channels.

Dr. Richard Hsieh, Chairman and Founder of AM BIOTECH for his leading Biochemical Pulse Exosomes, he particularly emphasized that exosome manufacturers around the world are planning for globalization in the international market, and AM BIOTECH is no exception. Although South Korea, Japan and even Taiwan have opened to use human Cell-derived exosomes for cosmetic raw materials, but in order to be able to integrate with the international market, so that the products can go out of Taiwan and take a global view, they must comply with the cosmetics regulations of most mainstream international markets. It can be seen that there is no company that used human-derived exosomes has joined the 2024 In-cosmetics Global exhibition.

AM BIOTECH ExoGiov® exosome complies with international standards and regulations acceptable worldwide, which is specific-pathogen-free (SPF) chicken embryonic mesenchymal cell-derived extracellular vesicles, and the others ordinary exosomes are mostly plant-derived exosomes. Furthermore, ExoGiov® is the world’s only Bio-pulsed exosome raw material for inducing facial beauty and hair growth functions.

This innovation breakthrough is the core of ExoGiov® patented biochemical pulsed functional-inducing-exosome technology, it can precisely regulate the expression of miRNA genes to make it better than ordinary Exosomes and general cosmetic raw materials. The effectiveness of ExoGiov® are dozens of times more effective in facial beauty and hair health, such as collagen type I and type III, elastin, skin fibroblast proliferation, melanin degradation, and hair follicle cell proliferation. It has produced excellent results in all aspects.

AM BIOTECH’s latest research on promoting hair follicle cell proliferation, it was further found that Minoxidil (the active ingredient of Rogaine) has an 87% hair follicle cell proliferation rate and a 20% hair follicle cell proliferation rate with generally non-functional inducing exosomes. The hair follicle cell proliferation rate of AM BIOTECH BIO-Pulsed Exosomes is 113%, and its efficacy is very outstanding.

AM BIOTECH Bio-Pulsed Exosomes has innovation break through on this cosmetic application, the storage and the regulation limitation. ExoGiov® patented biochemical pulsed functional-inducing-exosome has the uniqueness of 99.99% high-purity exosomes and can be stored at room temperature, they comply with the international cosmetic regulations and banning exosomes derived from human cells in most countries. The exosomes are the uniqueness of 99.99% high-purity exosomes and can be stored at room temperature.Most of the exosomes currently on the market are need to be keep in frozen temperature or refrigerated in low temperature to ensure bioactivity, their application in the development and application of cosmetic products is very limited.

AM BIOTECH entered into the top five finalist’s breakthrough innovation cosmetics raw materials in the world for the Estée Lauder (NIV) BRKTHRU VOICES Prize at 2024 In-cosmetics Global. ExoGiov® BIO-Pulsed Exosomes demonstrates its development advantages in the international market, the Estée Lauder (NIV) Executive Officer Mr. Ryan J. Piela and his expert team also saw these advantages and characteristics of AM BIOTECH Biochemical-Pulsed Exosomes. This professional recognition from Estée Lauder company has also prompted many other international cosmetics brands and cosmetics ingredients distributor agents from various international countries to inquire about AM BIOTECH the exosomes business cooperation.

AM BIOTECH becomes the first Taiwan’s exosomes to enter the international market, the Glory of Taiwan.  AM BIOTECH has officially launched the ExoGiov® Bio-pulsed exosomes in use and application in the cosmetics ingredient and LA EXO® related skincare & haircare products.

Read Moreread more

Join Us at Cosmopack Asia 2025

2025-10-23

AM Biotech is honored to participate in Cosmopack Asia 2025, where we will present our

Join Us at the 2025 Autumn International Beauty & Cosmetics Show

2025-09-15

Ascension Medical Biotechnology is dedicated to the research and development of functionally induced exosomes. With

AM Biotech Expands into ASEAN Market at Malaysia-Taiwan Great Health Exhibition Centre

2025-07-18

Taiwan Great Health Exhibition Centre Opens in Kuala Lumpur, Showcasing Healthcare Innovation

According to the EUROPE DIRECT CONTACT CENTER consultation response summary (full response attached):

All cosmetics related to animal sources and derived ingredients will be labeled ANNEX II/419. However, this is only for reference and not as a basis for restriction/prohibition.

Furthermore, according to cosmetics regulations (1223/2009), the responsible person must ensure the safety of cosmetics on the market and assume corresponding responsibilities when using or not using such ingredients, and demonstrate whether the entries indicated in CosIng are related to these ingredients.

The ingredient “chicken embryonic mesenchymal cell-derived extracellular vesicles” from ExoGiov comes from SPF (Specific Pathogen Free) chicken eggs and does not fall under the categories mentioned in ANNEX II/419. It also has a safety report from a third-party inspection company, ensuring its safety for use in cosmetics.

Europe Direct Contact Centre <EuropeDirectContactCentre@edcc.ec.europa.eu>

Your Europe Direct reply no #3662921

Dear Mr S. H. Lee,

Thank you for contacting the Europe Direct Contact Centre.

We have consulted the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW). Please find below the answer to your question.

“CosIng has only informative value, it is not a legally binding instrument. In addition, entry II/419 refers to ‘Category 1 material and Category 2 material as defined in Articles 4 and 5 respectively of Regulation (EC) No 1774/2002 of the European Parliament and of the Council ( 3 ), and ingredients derived therefrom”. This is added for information purposes. And it does not service as a restriction/prohibition as such.

According to the Cosmetics Regulation (1223/2009), the responsible person must ensure the safety of the cosmetic product placed on the market and has the respective responsibility in using or not such ingredients in cosmetics and attest whether the entry indicated in CosIng is relevant to these ingredients or not.

We hope you find this information useful. Please contact us again if you have other questions about the European Union, its activities or institutions.”

We hope you find this information useful. Please contact us again if you have other questions about the European Union, its activities or its institutions.

With kind regards,
Europe Direct Contact Centre
We answer all questions about the EU

Read Moreread more

Join Us at Cosmopack Asia 2025

2025-10-23

AM Biotech is honored to participate in Cosmopack Asia 2025, where we will present our

Join Us at the 2025 Autumn International Beauty & Cosmetics Show

2025-09-15

Ascension Medical Biotechnology is dedicated to the research and development of functionally induced exosomes. With

AM Biotech Expands into ASEAN Market at Malaysia-Taiwan Great Health Exhibition Centre

2025-07-18

Taiwan Great Health Exhibition Centre Opens in Kuala Lumpur, Showcasing Healthcare Innovation